PharmaLectures.com

Courses › Pharma training by role › Pharmacovigilance and medical: working with European counterparts, minus the friction

Pharmacovigilance and medical: working with European counterparts, minus the friction

Your team writes safety documents Europe accepts on the first read.

  • 6 audio modulesthree lengths each
  • 1 h to 5 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Pharmacovigilance and medicalwho it is written for

Why this training matters

A signal email reaches your European colleague with a United States term in it. The reply asks what you mean, then asks again. The European Medicines Agency can stop the review clock while questions wait, and your team spends the weeks rewriting instead of filing.

What changes after this course

Your team drafts to European expectations the first time and writes emails that get answered the same day. You hold a certificate for each learner and a training record for every person, ready when an auditor asks who was trained.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your safety physician stops asking Legal who owns a decision. The roles of the Qualified Person for Pharmacovigilance, the marketing authorisation holder and the national competent authority are clear, and Directive 2001/83/EC and Regulation (EC) No 726/2004 become documents you can check yourself. Your Pharmacovigilance System Master File entries read the same way to an inspector as they do to you.

A medical information request that describes an adverse event no longer sits in an inbox. Your team recognises it, routes it to safety and answers the requester within the rules. Medical Science Liaisons know where real-world evidence collection stops, and where medical information ends and promotion begins under European rules.

Signal meetings end with an owner and a date. Your team runs detection and validation under Good Pharmacovigilance Practices Module IX, and sends safety communication that follows Module XV. Emails drop the terms that mean one thing in the United States and another in Europe, so your counterpart answers instead of asking what you meant.

Risk Management Plans go out with fewer questions attached, because your team writes them to Good Pharmacovigilance Practices Module V and splits the work between medical and pharmacovigilance clearly. When an inspector arrives under Module III, your people answer from the record, and the audit records under Module IV are already in the folder.

Who needs this training

  • Pharmacovigilance Manager

    You review a Risk Management Plan draft at the end of the day and find the same structural gaps as last time. Afterwards, the draft arrives built to Good Pharmacovigilance Practices Module V.

  • Medical Affairs Liaison

    You get a promotional review back for the third time. Afterwards, you know where the European line between medical information and promotion sits, and your reply passes the first time.

  • Drug Safety Associate

    A medical colleague abroad sends a case with half the facts missing. Afterwards, your follow-up request brings back a complete answer, and you enter the case within the European reporting timelines.

  • Regulatory Affairs Specialist

    The call comes that an inspection is announced. Afterwards, the Pharmacovigilance System Master File, the audit records and the Risk Management Plan history are in hand before the opening meeting.

Roles: Pharmacovigilance and medical

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Name which duties sit with the Qualified Person for Pharmacovigilance and which sit with the marketing authorisation holder.
  2. Write a Pharmacovigilance System Master File contribution that matches Good Pharmacovigilance Practices Module II.
  3. Route a medical information request that describes an adverse event to the safety team, with the facts they need.
  4. Rewrite a safety email so it names the decision needed, the owner and the date.
  5. Set up signal detection steps that follow Good Pharmacovigilance Practices Module IX and record who decided what.
  6. Structure a Risk Management Plan so reviewers can trace each safety concern to its risk minimisation measure.
  7. Assemble the documents an inspector asks for first before the opening meeting of a pharmacovigilance inspection.

What the company gets

  • Risk Management Plans reach the European Medicines Agency or the national competent authority with fewer questions attached, so review clocks are less likely to stop.
  • The Pharmacovigilance System Master File stays consistent with what your people say, so an inspector finds the same story in the file and in the room.
  • Medical information and safety teams stop trading revisions across borders, and your staff get their hours back for the work that moves submissions forward.
  • Your people answer inspector questions on the audit trail and on signal detection from the record, not from memory.
  • You hold a certificate for each learner and a training record per person, ready for the next audit.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 6 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 30 min25 min a module, for regulatory, quality and business-development staff
Expanded5 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Pharmacovigilance and medicalStandard2 h 30 min

Course outline: 6 modules

6 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Apply the European pharmacovigilance framework to your daily calls

    • Which decisions belong to the Qualified Person for Pharmacovigilance, and which you can make today.
    • How to write a Pharmacovigilance System Master File entry that an inspector reads once and accepts.
    • The reporting duties in Directive 2001/83/EC that you can now check yourself instead of asking Legal.
  2. 2Align medical information answers with European regulatory requirements

    • What to do when a medical information request turns out to describe an adverse event.
    • When a Medical Science Liaison may collect real-world evidence, and when to stop the conversation.
    • The line between promotional material and a medical information reply that European reviewers accept.
  3. 3Write safety and medical emails that European colleagues answer today

    • How to build a safety email so your European counterpart can answer it the same day.
    • Why a term that is routine in the United States sends a European colleague back with questions.
    • How to close a signal detection meeting with one named owner and one date.
  4. 4Coordinate signal detection under Good Pharmacovigilance Practices Module IX

    • How to set up signal detection so it meets Good Pharmacovigilance Practices Module IX on first review.
    • What to do when an urgent safety restriction lands, and which clocks start the moment you know.
    • The steps to submit a safety variation to the right European authority without a rejected file.
  5. 5Draft European Risk Management Plans that draw fewer regulatory questions

    • Why national competent authorities send a Risk Management Plan back, and how to stop it.
    • How medical and pharmacovigilance teams split the Risk Management Plan so nothing is written twice.
    • The Risk Management Plan structure that reviewers can follow from safety concern to measure.
  6. 6Answer European pharmacovigilance inspectors accurately on the first ask

    • What a European pharmacovigilance inspector asks for first, so the answer is already on the table.
    • How to answer a question about your audit trail in two sentences that match the record.
    • The documents to have ready before the opening meeting, so nobody leaves the room to look.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

6 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h in the briefing length and 5 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Pharmacovigilance and medical. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 54 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team